We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$55.7B
AUM Growth
-$11.4B
Cap. Flow
-$9.72B
Cap. Flow %
-17.45%
Top 10 Hldgs %
9.49%
Holding
4,137
New
382
Increased
1,324
Reduced
1,495
Closed
773

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
YHOO
Yahoo Inc
YHOO
+$342M
3
BAC icon
Bank of America
BAC
+$322M
4
C icon
Citigroup
C
+$260M
5
BKNG icon
Booking.com
BKNG
+$219M

Sector Composition

Rank Sector Weight
1 Healthcare 13.78%
2 Technology 11.11%
3 Financials 10%
4 Consumer Discretionary 8.83%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MR
2926
DELISTED
Montage Resources Corporation Common Stock
MR
$353K ﹤0.01%
+16,347
New +$267K
FMI
2927
DELISTED
Foundation Medicine, Inc.
FMI
$353K ﹤0.01%
+19,397
New +$313K
COLL icon
2928
Collegium Pharmaceutical
COLL
$841M
$352K ﹤0.01%
19,383
+9,579
+98% +$174K
CNS icon
2929
Cohen & Steers
CNS
$4.22B
$350K ﹤0.01%
8,991
-27,579
-75% -$868K
MFIN icon
2930
Medallion Financial
MFIN
$268M
$350K ﹤0.01%
37,924
+21,884
+136% +$167K
NTAP icon
2931
NetApp
NTAP
$37.3B
$349K ﹤0.01%
12,805
-49,914
-80% -$1.21M
SUP
2932
DELISTED
Superior Industries International
SUP
$349K ﹤0.01%
15,785
+3,278
+26% +$64.3K
TK icon
2933
PUT
Teekay
TK
$1.16B
$346K ﹤0.01%
40,000
-20,000
-33% -$151K
MMI icon
2934
Marcus & Millichap
MMI
$1.23B
$343K ﹤0.01%
+13,501
New +$316K
CIM
2935
Chimera Investment
CIM
$969M
$342K ﹤0.01%
+8,393
New +$326K
DHC
2936
Diversified Healthcare Trust
DHC
$1.94B
$341K ﹤0.01%
19,038
-39,892
-68% -$623K
WBK
2937
DELISTED
Westpac Banking Corporation
WBK
$340K ﹤0.01%
14,630
-23,244
-61% -$517K
CZR
2938
CALL
DELISTED
Caesars Entertainment Corporation
CZR
$340K ﹤0.01%
50,000
-50,000
-50% -$350K
ARI
2939
Apollo Commercial Real Estate
ARI
$882M
$337K ﹤0.01%
20,704
-66,367
-76% -$1.07M
SUPN icon
2940
Supernus Pharmaceuticals
SUPN
$2.59B
$336K ﹤0.01%
22,010
-3,915
-15% -$51.1K
OXFD
2941
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$336K ﹤0.01%
33,946
+1,423
+4% +$14.6K
MLM icon
2942
PUT
Martin Marietta Materials
MLM
$37.5B
$335K ﹤0.01%
2,100
-30,500
-94% -$4.19M
O icon
2943
Realty Income
O
$59.4B
$334K ﹤0.01%
5,522
LXK
2944
CALL
DELISTED
Lexmark Intl Inc
LXK
$334K ﹤0.01%
10,000
-41,000
-80% -$1.21M
LAD icon
2945
Lithia Motors
LAD
$8.04B
$332K ﹤0.01%
+3,800
New +$326K
PFS icon
2946
Provident Financial Services
PFS
$3.06B
$331K ﹤0.01%
+16,406
New +$312K
WINA icon
2947
Winmark
WINA
$1.24B
$331K ﹤0.01%
3,380
+4
+0.1% +$382
SPLS
2948
PUT
DELISTED
Staples Inc
SPLS
$331K ﹤0.01%
30,000
-100,000
-77% -$940K
AUB icon
2949
Atlantic Union Bankshares
AUB
$5.83B
$329K ﹤0.01%
+13,344
New +$308K
GARS
2950
DELISTED
Garrison Capital Inc.
GARS
$329K ﹤0.01%
30,640
+11,106
+57% +$124K

Similar funds

David Shaw's Q1 2016 Portfolio in Review

As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.

  • David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
  • David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
  • David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
  • David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
  • David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
  • David Shaw opened 382 new positions and closed 773 in Q1 2016.
  • David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.